Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

AVI confirms that classic approaches valid for testing antisense compound

April 22, 1999

Angiotensin immunization as an immunotherapeutic approach to hypertension

April 21, 1999

Gene therapy for congestive heart failure studied in mice

April 21, 1999

Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis

April 20, 1999

News from FASEB: ETA antagonist with potential in the treatment of pulmonary hypertension

April 19, 1999

Bay-y-5959 is not associated with proarrhythmic activity in dogs with CHF

April 19, 1999

Phenoxypyridine inhibitors of Na+/Ca2+ exchange from Taisho

April 19, 1999

HMR continues to focus R&D resources in the area of Na+/H+ exchange inhibitors

April 14, 1999

Tularik presents novel compounds with dual antiproliferative and hypolipidemic effects

April 9, 1999

E-047/1 more effective than known antiarrhythmics against ventricular fibrillation

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...